Literature DB >> 8916075

Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms.

J M Masserano1, I Baker, N Natsukari, R J Wyatt.   

Abstract

Tyrosine hydroxylase activity was measured in the brain of rats treated chronically with saline or cocaine (10 mg/kg, 2 x day, for 7 days). Tyrosine hydroxylase activity was significantly increased in the ventral tegmental area 1, 6 and 12 weeks after the last treatment with cocaine. The increase in tyrosine hydroxylase activity at 6 weeks after the last cocaine injection was prevented by the prior administration of MK-801, haloperidol or clozapine but not by the D1 receptor antagonist, SCH-23390. SCH-23390 produced a significant increase in tyrosine hydroxylase activity when administered with saline. These data indicate that glutaminergic and dopaminergic D2-receptor mediated mechanisms are important in regulating the effect of cocaine on the ventral tegmental area.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916075

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats.

Authors:  Richard M Allen; Linda A Dykstra; Regina M Carelli
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

2.  Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.

Authors:  Sirirat Klongpanichapak; Piyarat Govitrapong; Sushil K Sharma; Manuchair Ebadi
Journal:  Neurochem Res       Date:  2006-03       Impact factor: 3.996

3.  Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade.

Authors:  R C Pierce; A F Pierce-Bancroft; B M Prasad
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

4.  Parent-offspring cohabitation after weaning inhibits partner preference and alters central oxytocin and dopamine systems in adult mandarin vole.

Authors:  Ruiyong Wu; Zhenzhen Song; Fadao Tai
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2018-04-18       Impact factor: 1.836

5.  Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice.

Authors:  V A Boundy; S J Gold; C J Messer; J Chen; J H Son; T H Joh; E J Nestler
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  Identification of tyrosine hydroxylase as a physiological substrate for Cdk5.

Authors:  Janice W Kansy; S Colette Daubner; Akinori Nishi; Naoki Sotogaku; Michael D Lloyd; Chan Nguyen; Lin Lu; John W Haycock; Bruce T Hope; Paul F Fitzpatrick; James A Bibb
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

7.  Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist.

Authors:  C Flores; D Rodaros; J Stewart
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

8.  The neuronal nitric oxide synthase (nNOS) gene contributes to the regulation of tyrosine hydroxylase (TH) by cocaine.

Authors:  Mara A Balda; Karen L Anderson; Yossef Itzhak
Journal:  Neurosci Lett       Date:  2009-04-09       Impact factor: 3.046

Review 9.  Extinction training regulates neuroadaptive responses to withdrawal from chronic cocaine self-administration.

Authors:  David W Self; Kwang-Ho Choi; Diana Simmons; John R Walker; Cynthia S Smagula
Journal:  Learn Mem       Date:  2004 Sep-Oct       Impact factor: 2.460

10.  Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat.

Authors:  Jack D Shepard; David T Chuang; Yavin Shaham; Marisela Morales
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.